Kenneth E.S. Poole
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kenneth E.S. Poole has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Graham M. Treece
Department of Engineering, University of Cambridge, Cambridge, U.K.
3 shared publications - Jonathan Reeve
NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK
2 shared publications - Nigel Loveridge
Department of Medicine, University of Cambridge, Cambridge, United Kingdom
2 shared publications - P. M. Mayhew
University of Cambridge Department of Medicine, Level 5, Addenbrooke’s Hospital (Box 157), Hills Road, Cambridge CB2 2QQ, UK
2 shared publications A. Ginawi
Department of Medicine, Division of Rheumatology, Department of Clinical Biochemistry and Department of Medicine, Division of Bone Research, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK
1 shared publication- A. H. Gee
University of Cambridge Department of Engineering, Trumpington Street, Cambridge CB2 1PZ, UK
1 shared publication
Latest Publications
- Open Access
- 1 July 2012
- Published by Elsevier in Medical Image Analysis
- Vol. 16 (5) , 952-965
Imaging the femoral cortex: Thickness, density and mass from clinical CT
- 1 July 2012
- Published by Elsevier in Medical Image Analysis
- Vol. 16 (5) , 952-965
Open AccessImaging the femoral cortex: Thickness, density and mass from clinical CT
- Open Access
- 1 June 2010
- Published by Elsevier in Medical Image Analysis
- Vol. 14 (3) , 276-290
High resolution cortical bone thickness measurement from clinical CT data
- 1 June 2010
- Published by Elsevier in Medical Image Analysis
- Vol. 14 (3) , 276-290
Open AccessHigh resolution cortical bone thickness measurement from clinical CT data
- Open Access
- 27 January 2010
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 25 (3) , 482-491
Changing structure of the femoral neck across the adult female lifespan
The anatomic distribution of cortical and cancellous bone in the femoral neck may be critical in determining resistance to fracture. We investigated the effects of aging on femoral neck bone in women. In this cross-sectional study, we used clinical multidetector computed tomography (MDCT) of the hips to investigate aging effects in 100 female volunteers aged 20 to 90 years. We developed a clinically efficient protocol to measure cortical thickness (C.Th) and cortical, trabecular, and integral bone mineral density (CtBMD, TrBMD, and iBMD in mg/cm3) in anatomic quadrants of the femoral neck. We used a nested ANOVA to evaluate their associations with height, weight, location in the femoral neck, and age of the subject. Age was the principal determinant of both cortical thickness and BMD. Age had significantly different effects within the anatomic quadrants; compared with young women, elderly subjects had relative preservation of the inferoanterior (IA) quadrant but strikingly reduced C.Th and BMD superiorly. A model including height, weight, and region of interest (and their interactions) explained 83% of the measurement variance (p < .0001). There were marked C.Th and BMD differences between age 25 and age 85 in the already thin superior quadrants. At 25 years the predicted C.Th of the superoposterior quadrant was 1.63 mm, whereas at 85 years it was 0.33 mm [−1.33 mm, 95% confidence interval (CI) of difference over 60 years −1.69 to −0.95]. By contrast, at 25 years mean C.Th of the IA quadrant was 3.9 mm, whereas at 85 years it was 3.3 mm (−0.6 mm, 95% CI −0.83 to −0.10). CtBMD of the IA region was equivalent at 25 and 85 years. In conclusion, elderly women had relative preservation of IA femoral neck bone over seven decades compared with young women but markedly lower C.Th and BMD in the other three quadrants. The IA quadrant transmits mechanical load from walking. Mechanical theory and laboratory tests on cadaveric femurs suggest that localized bone loss may increase the risk of fracture in elderly fallers. It remains to be determined whether this MDCT technique can provide better prediction of hip fracture than conventional clinical dual X-ray absorptiometry (DXA). © 2010 American Society for Bone and Mineral Research
- 27 January 2010
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 25 (3) , 482-491
Open AccessChanging structure of the femoral neck across the adult female lifespan
The anatomic distribution of cortical and cancellous bone in the femoral neck may be critical in determining resistance to fracture. We investigated the effects of aging on femoral neck bone in women. In this cross-sectional study, we used clinical multidetector computed tomography (MDCT) of the hips to investigate aging effects in 100 female volunteers aged 20 to 90 years. We developed a clinically efficient protocol to measure cortical thickness (C.Th) and cortical, trabecular, and integral bone mineral density (CtBMD, TrBMD, and iBMD in mg/cm3) in anatomic quadrants of the femoral neck. We used a nested ANOVA to evaluate their associations with height, weight, location in the femoral neck, and age of the subject. Age was the principal determinant of both cortical thickness and BMD. Age had significantly different effects within the anatomic quadrants; compared with young women, elderly subjects had relative preservation of the inferoanterior (IA) quadrant but strikingly reduced C.Th and BMD superiorly. A model including height, weight, and region of interest (and their interactions) explained 83% of the measurement variance (p < .0001). There were marked C.Th and BMD differences between age 25 and age 85 in the already thin superior quadrants. At 25 years the predicted C.Th of the superoposterior quadrant was 1.63 mm, whereas at 85 years it was 0.33 mm [−1.33 mm, 95% confidence interval (CI) of difference over 60 years −1.69 to −0.95]. By contrast, at 25 years mean C.Th of the IA quadrant was 3.9 mm, whereas at 85 years it was 3.3 mm (−0.6 mm, 95% CI −0.83 to −0.10). CtBMD of the IA region was equivalent at 25 and 85 years. In conclusion, elderly women had relative preservation of IA femoral neck bone over seven decades compared with young women but markedly lower C.Th and BMD in the other three quadrants. The IA quadrant transmits mechanical load from walking. Mechanical theory and laboratory tests on cadaveric femurs suggest that localized bone loss may increase the risk of fracture in elderly fallers. It remains to be determined whether this MDCT technique can provide better prediction of hip fracture than conventional clinical dual X-ray absorptiometry (DXA). © 2010 American Society for Bone and Mineral Research
- Open Access
- 4 April 2008
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 47 (9) , 1348-1351
Hypovitaminosis D among rheumatology outpatients in clinical practice
Objectives. A role for vitamin D in the pathogenesis of autoimmune and inflammatory diseases is emerging. We undertook an audit of 25-hydroxyvitamin D (25OHD) investigation and treatment in rheumatology outpatients. Methods. Serum 25OHD requests were matched to electronic medical records from rheumatology and metabolic bone clinics (April 2006–March 2007). Data were analysed separately for two groups, ‘Documented osteoporosis/osteopaenia’ (Group 1) and ‘General rheumatology outpatients’ (Group 2, sub-divided by diagnosis). Hypovitaminosis D was defined by 25OHD levels z-scores. Results. A total of 263 patients were included (Group 1, n = 122; Group 2, n = 141) with an overall median 25OHD of 44 nmol/l.The 25OHD level among general rheumatology patients (median 39 nmol/l, mean z score −1.2, was statistically significantly lower than among osteoporotic/osteopaenic patients (median 49 nmol/l, mean z score of −0.9, p < 0.05 for the difference). 25OHD was lower in inflammatory arthritis and chronic pain/fibromyalgia than in other groups. Prescribing was recorded in 100 in Group 1 (of whom 95% were prescribed calcium/800 IU cholecalciferol) and 83 in Group 2 (91% calcium/800 IU). Only 31% of the patients with 25OHD Conclusions. Improved guidelines for managing hypovitaminosis D in rheumatology patients are needed. We found a high prevalence of hypovitaminosis D among secondary care patients in rheumatology and widespread supplementation with 800 IU cholecalciferol. Substantially reduced levels of serum 25OHD were identified among patients with inflammatory arthritis and chronic pain.
- 4 April 2008
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 47 (9) , 1348-1351
Open AccessHypovitaminosis D among rheumatology outpatients in clinical practice
Objectives. A role for vitamin D in the pathogenesis of autoimmune and inflammatory diseases is emerging. We undertook an audit of 25-hydroxyvitamin D (25OHD) investigation and treatment in rheumatology outpatients. Methods. Serum 25OHD requests were matched to electronic medical records from rheumatology and metabolic bone clinics (April 2006–March 2007). Data were analysed separately for two groups, ‘Documented osteoporosis/osteopaenia’ (Group 1) and ‘General rheumatology outpatients’ (Group 2, sub-divided by diagnosis). Hypovitaminosis D was defined by 25OHD levels z-scores. Results. A total of 263 patients were included (Group 1, n = 122; Group 2, n = 141) with an overall median 25OHD of 44 nmol/l.The 25OHD level among general rheumatology patients (median 39 nmol/l, mean z score −1.2, was statistically significantly lower than among osteoporotic/osteopaenic patients (median 49 nmol/l, mean z score of −0.9, p < 0.05 for the difference). 25OHD was lower in inflammatory arthritis and chronic pain/fibromyalgia than in other groups. Prescribing was recorded in 100 in Group 1 (of whom 95% were prescribed calcium/800 IU cholecalciferol) and 83 in Group 2 (91% calcium/800 IU). Only 31% of the patients with 25OHD Conclusions. Improved guidelines for managing hypovitaminosis D in rheumatology patients are needed. We found a high prevalence of hypovitaminosis D among secondary care patients in rheumatology and widespread supplementation with 800 IU cholecalciferol. Substantially reduced levels of serum 25OHD were identified among patients with inflammatory arthritis and chronic pain.